SPDR S&P Biotech ETF (XBI) Dividend History

Dividend Yield: 0.04%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 25, 2025 $0.01 06/23/2025 06/23/2025
March 26, 2025 $0.01 03/24/2025 03/24/2025
December 26, 2024 $0.00 12/23/2024 12/23/2024
September 25, 2024 $0.02 09/23/2024 09/23/2024
June 26, 2024 $0.11 06/24/2024 06/24/2024
Show more

Dividends Summary

  • SPDR S&P Biotech ETF has issued 44 dividend payments over the past 18 years
  • The most recent dividend was paid 28 days ago, on June 25, 2025
  • The first recorded dividend was paid on June 27, 2007
  • The highest dividend payout was $0.67 per share
  • The average dividend over this 18 year span is $0.12 per share
  • SPDR S&P Biotech ETF has decreased its dividend payments by 94.66% since 2007

Company News

  • Bank of America's chief investment strategist Michael Hartnett recommends buying long-duration bonds as yields stabilize and the potential for lower government deficits under the Trump administration. He suggests four ETFs to watch: iShares 20+ Year Treasury Bond ETF (TLT), SPDR S&P Biotech ETF (XBI), SPDR Homebuilders ETF (XHB), and SPDR Utilities Select Sector Fund (XLU).

    Benzinga
    Featured Companies: TLT XHB XLU
  • The biotech industry has lagged the broader market in 2024, but CRISPR Therapeutics and Exelixis still look like solid long-term picks. CRISPR Therapeutics has a promising gene-editing therapy, while Exelixis' cancer drug Cabometyx continues to drive strong financial results.

    The Motley Fool
    Featured Companies: CRSP EXEL
  • The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. The appointment of RFK Jr. to lead the Department of Health and Human Services has spooked investors with his controversial policies and vaccine skepticism, leading to a decline in sector giants like Pfizer.

    Investing.com
    Featured Companies: IBB MRNA NVAX PFE
  • The First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange-traded fund that provides broad exposure to the healthcare-biotech sector. The ETF tracks the NYSE Arca Biotechnology Index and has a relatively high expense ratio of 0.56%. Its top holdings include Alnylam Pharmaceuticals, Corcept Therapeutics, and United Therapeutics.

    Zacks Investment Research
    Featured Companies: ALNY CORT FBT IBB UTHR
  • Bubbles in the AI sector are deflating, while rising interest rates are impacting the commercial real estate sector. Read more to see my thoughts.

    Seeking Alpha
    Featured Companies: BAC KEY MIRM NVDA PFE SMCI
Page data last updated 07/23/2025 08:07:01 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included